IDO1 and breast carcinoma: In order to characterize the respective levels of activity of the IDO-Kyn-Trp pathway in different syngeneic mouse tumor models, we quantified Kynurenine and Tryptophan levels in the extracellular space of the tumor using intratumoral microdialysis in each of the following models: CT26 colon cancer, A20 lymphoma, EMT6 breast cancer, and MC205 sarcoma models.